Cycloplatam: A novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatin
作者： M. Drees , W.M. Dengler , H.R. Hendriks , L.R. Kelland , H.H. Fiebig
DOI: 10.1016/0959-8049(94)00513-5
关键词:
摘要: … After 10 days, tumours were dissected out, and tumour weights in control and treated groups were compared. Anti-tumour activity was defmed in terms of a therapeutic index (TI), the …
elsevier.com
sci-hub.se 
researchgate.net 参考文章(27)
Robert F. Ozols, Chemotherapy of ovarian cancer. Seminars in Oncology. ,vol. 18, pp. 219- 234 ,(1998) , 10.1007/978-1-4615-5447-9_7
H. H. Fiebig, H. A. Neumann, H. Henß, H. Koch, D. Kaiser, H. Arnold, Development of Three Human Small Cell Lung Cancer Models in Nude Mice Recent results in cancer research. ,vol. 97, pp. 77- 86 ,(1985) , 10.1007/978-3-642-82372-5_8
Patrick J Loehrer, LAWRENCE H EINHORN, Cisplatin Annals of Internal Medicine. ,vol. 100, pp. 704- 713 ,(1984) , 10.7326/0003-4819-100-5-704
Archie W. Prestayko, Bristol Laboratories, Stephen K. Carter, Stanley T. Crooke, Cisplatin : current status and new developments Academic Press. ,(1980)
Wilma M. McKoy, Karen R. Grotzinger, Karen G. Louie, Robert F. Ozols, Turid Knutsen, Robert C. Young, Brent C. Behrens, Brent C. Behrens, Jacqueline Whang-Peng, Thomas C. Hamilton, Hidetaka Masuda, Characterization of a cis-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues Cancer Research. ,vol. 47, pp. 414- 418 ,(1987)
Prakash Mistry, Ciaran F. O'Neill, Swee Y. Loh, Barry A. Murrer, George Abel, Kenneth R. Harrap, Lloyd R. Kelland, Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Research. ,vol. 52, pp. 3857- 3864 ,(1992)
Phyllis M. Goddard, Melanie Valenti, Mervyn Jones, Barry A. Murrer, George Abel, Mark J. McKeage, Kenneth R. Harrap, Lloyd R. Kelland, Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Cancer Research. ,vol. 53, pp. 2581- 2586 ,(1993)
C. Mangioni, G. Bolis, S. Pecorelli, K. Bragman, A. Epis, G. Favalli, A. Gambino, F. Landoni, M. Presti, W. Torri, L. Vassena, F. Zanaboni, S. Marsoni, Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin Journal of the National Cancer Institute. ,vol. 81, pp. 1464- 1471 ,(1989) , 10.1093/JNCI/81.19.1464
J Siracky, AP Wilson, KR Harrap, CA Hills, LR Kelland, G Abel, Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. British Journal of Cancer. ,vol. 59, pp. 527- 534 ,(1989) , 10.1038/BJC.1989.108
Barnett Rosenberg, Charles F. Kettring prize. Fundamental studies with cisplatin Cancer. ,vol. 55, pp. 2303- 2316 ,(1985) , 10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L